Salivary Cytokines as Potential Diagnostic Biomarkers for Systemic Lupus Erythematosus Disease
Open Access
- 1 January 2021
- journal article
- review article
- Published by Wiley in Mediators of Inflammation
- Vol. 2021 (1)
Abstract
Systemic lupus erythematosus (SLE) is a complex autoimmune inflammatory disease characterized by an unknown etiology and a highly variable clinical presentation. This clinical heterogeneity might be explained by dysregulation of tolerance to self and apoptotic mechanisms, overproduction of autoantibodies, and abnormal cytokine levels. Cytokine imbalance levels have been associated with disease activity and severity in SLE patients. In the last years, salivary cytokines related to SLE have gained significant attention and researchers have begun to focus on the identification of cytokines in the saliva of SLE patients using it as a diagnostic fluid for the inflammatory process underlying SLE. This review highlights and summarizes recent studies revealing the cytokines that have been identified in the saliva of individuals with SLE. Data reported and discussed in this report may provide useful additional information to better understand the mechanisms associated with the disease.Keywords
This publication has 79 references indexed in Scilit:
- Cytokine disturbances in systemic lupus erythematosusArthritis Research & Therapy, 2011
- Lupus nephritis: current updateArthritis Research & Therapy, 2011
- Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosusArthritis Research & Therapy, 2010
- Interferon‐regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation studyArthritis & Rheumatism, 2009
- Lack of association between the interferon-α signature and longitudinal changes in disease activity in systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2009
- Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patientsArthritis Research & Therapy, 2008
- Historical insights into cytokinesEuropean Journal of Immunology, 2007
- High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosusGenes & Immunity, 2007
- Elevated Serum Levels of Interferon-Regulated Chemokines Are Biomarkers for Active Human Systemic Lupus ErythematosusPLOS Medicine, 2006
- Interleukin-1 and Interleukin-6 Activities are Increased in the Cerebrospinal Fluid of Patients with CNS Lupus Erythematosus and Correlate with Local Late T-Cell Activation MarkersLupus, 1992